Kim Hong Kwan, Choi Yong Soo, Kim Kwhanmien, Kim Jhingook, Shim Young Mog
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea.
Lung Cancer. 2007 Dec;58(3):342-7. doi: 10.1016/j.lungcan.2007.07.001. Epub 2007 Sep 7.
An unsuspected adrenal mass (AM) could be discovered in patients with operable non-small-cell lung carcinoma (NSCLC), but it is difficult to determine the nature of AM. The purpose of the study is to answer the question as to which decision should be made when assessing AM in patients with NSCLC.
From 1997 to 2005, 40 patients (31 male; mean age: 63 years) were identified to have both NSCLC and AM. We tried to determine the nature of AM based on imaging studies with or without laparoscopic adrenalectomy. When AM was considered benign on CT or PET-CT, surgical resection of NSCLC was performed (group 1, n=25). When AM was considered indeterminate on CT or PET-CT, we performed MRI to determine the operability. In eight patients, surgical resection of NSCLC was performed, because AM was considered benign on MRI (group 2). In seven patients, adrenalectomy was performed to confirm AM pathologically, because all imaging studies were indeterminate (group 3).
Follow-up was complete for all patients with a mean duration of 33.1 months (3-104.5). In group 1, no patients showed adrenal metastases, except one who died of adrenal metastasis. In group 2, three patients revealed that they had had adrenal metastases when staging and two died of adrenal metastasis. In group 3, one patient had an adrenal metastasis and the others had benign lesions.
We suggest that when AM is considered benign on CT or PET-CT, surgical resection of NSCLC is indicated. However, when AM is indeterminate on CT or PET-CT, histopathologic confirmation is needed to determine the nature of AM.
在可手术切除的非小细胞肺癌(NSCLC)患者中可能会发现意外的肾上腺肿块(AM),但很难确定AM的性质。本研究的目的是回答在评估NSCLC患者的AM时应做出何种决策的问题。
1997年至2005年,确定40例患者(31例男性;平均年龄:63岁)同时患有NSCLC和AM。我们试图通过影像学检查或联合腹腔镜肾上腺切除术来确定AM的性质。当CT或PET-CT显示AM为良性时,进行NSCLC手术切除(第1组,n = 25)。当CT或PET-CT显示AM性质不确定时,我们进行MRI检查以确定是否可手术。8例患者因MRI显示AM为良性而进行了NSCLC手术切除(第2组)。7例患者因所有影像学检查均不能明确诊断而进行肾上腺切除术以病理确诊AM(第3组)。
所有患者均完成随访,平均随访时间为33.1个月(3 - 104.5个月)。在第1组中,除1例死于肾上腺转移外,无患者出现肾上腺转移。在第2组中,3例患者分期时发现有肾上腺转移,2例死于肾上腺转移。在第3组中,1例患者有肾上腺转移,其他患者为良性病变。
我们建议,当CT或PET-CT显示AM为良性时,应行NSCLC手术切除。然而,当CT或PET-CT显示AM性质不确定时,需要进行组织病理学确诊以确定AM的性质。